메뉴 건너뛰기




Volumn 17, Issue 6, 2013, Pages 2143-2155

Adherence support approaches in biomedical HIV prevention trials: Experiences, insights and future directions from four multisite prevention trials

Author keywords

Adherence; Clinical trials; Counseling; HIV prevention; Intervention; Microbicides; PrEP

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

EID: 84879023679     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-013-0429-9     Document Type: Review
Times cited : (120)

References (43)
  • 1
    • 77955930318 scopus 로고    scopus 로고
    • Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women
    • Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329(5996):1168-74.
    • (2010) Science , vol.329 , Issue.5996 , pp. 1168-1174
    • Abdool Karim, Q.1    Abdool Karim, S.S.2    Frohlich, J.A.3    Grobler, A.C.4    Baxter, C.5    Mansoor, L.E.6
  • 3
    • 78650549662 scopus 로고    scopus 로고
    • Preexposure chemoprophylaxis for HIV prevention in men who have sex with men
    • Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587-99.
    • (2010) N Engl J Med. , vol.363 , Issue.27 , pp. 2587-2599
    • Grant, R.M.1    Lama, J.R.2    Anderson, P.L.3    McMahan, V.4    Liu, A.Y.5    Vargas, L.6
  • 5
    • 84864507852 scopus 로고    scopus 로고
    • Preexposure prophylaxis for HIV infection among African women
    • Van Damme L, Corneli A, Ahmed K, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012;367(5):411-22.
    • (2012) N Engl J Med. , vol.367 , Issue.5 , pp. 411-422
    • Van Damme, L.1    Corneli, A.2    Ahmed, K.3
  • 8
    • 84862849188 scopus 로고    scopus 로고
    • Pre-exposure prophylaxis for HIV prevention: How to predict success
    • 22153566 10.1016/S0140-6736(11)61852-7
    • Kashuba AD, Patterson KB, Dumond JB, Cohen MS. Pre-exposure prophylaxis for HIV prevention: how to predict success. Lancet. 2012;379(9835):2409-11.
    • (2012) Lancet , vol.379 , Issue.9835 , pp. 2409-2411
    • Kashuba, A.D.1    Patterson, K.B.2    Dumond, J.B.3    Cohen, M.S.4
  • 9
    • 58149161570 scopus 로고    scopus 로고
    • Adherence to biomedical HIV prevention methods: Considerations drawn from HIV treatment adherence research
    • 18838058 10.1007/s11904-008-0027-z
    • Stirratt MJ, Gordon CM. Adherence to biomedical HIV prevention methods: considerations drawn from HIV treatment adherence research. Curr HIV/AIDS Rep. 2008;5(4):186-92.
    • (2008) Curr HIV/AIDS Rep , vol.5 , Issue.4 , pp. 186-192
    • Stirratt, M.J.1    Gordon, C.M.2
  • 10
    • 83955164274 scopus 로고    scopus 로고
    • Antiretroviral prophylaxis: A defining moment in HIV control
    • 21771566 10.1016/S0140-6736(11)61136-7
    • Karim S, Karim QA. Antiretroviral prophylaxis: a defining moment in HIV control. Lancet. 2011;378(9809):e23-5.
    • (2011) Lancet , vol.378 , Issue.9809
    • Karim, S.1    Karim, Q.A.2
  • 11
    • 84868455990 scopus 로고    scopus 로고
    • Adherence to preexposure chemoprophylaxis: The behavioral bridge from efficacy to effectiveness
    • 22964887 10.1097/COH.0b013e3283582d4a
    • Amico KR. Adherence to preexposure chemoprophylaxis: the behavioral bridge from efficacy to effectiveness. Curr Opin HIV AIDS. 2012;7(6):542-8.
    • (2012) Curr Opin HIV AIDS , vol.7 , Issue.6 , pp. 542-548
    • Amico, K.R.1
  • 12
    • 84870295000 scopus 로고    scopus 로고
    • State of the science of adherence to pre-exposure prophylaxis and microbicide trials
    • 22932322 10.1097/QAI.0b013e31826f9962 1:CAS:528:DC%2BC38Xhs1entb3K
    • Muchomba FM, Gearing RE, Simoni JM, El-Bassel N. State of the science of adherence to pre-exposure prophylaxis and microbicide trials. J Acquir Immune Defic Syndr. 2012;61(4):490-8.
    • (2012) J Acquir Immune Defic Syndr , vol.61 , Issue.4 , pp. 490-498
    • Muchomba, F.M.1    Gearing, R.E.2    Simoni, J.M.3    El-Bassel, N.4
  • 16
    • 0026858763 scopus 로고
    • Changing AIDS-risk behavior
    • 1594721 10.1037/0033-2909.111.3.455 1:STN:280:DyaK383nvFCmug%3D%3D
    • Fisher JD, Fisher WA. Changing AIDS-risk behavior. Psychol Bull. 1992;111(3):455.
    • (1992) Psychol Bull , vol.111 , Issue.3 , pp. 455
    • Fisher, J.D.1    Fisher, W.A.2
  • 18
    • 14244252122 scopus 로고    scopus 로고
    • Clinician-initiated HIV risk reduction intervention for HIV-positive persons: Formative research, acceptability, and fidelity of the Options Project
    • 15385903 10.1097/01.qai.0000140605.51640.5c
    • Fisher JD, Cornman DH, Osborn CY, Amico KR, Fisher WA, Friedland GA. Clinician-initiated HIV risk reduction intervention for HIV-positive persons: formative research, acceptability, and fidelity of the Options Project. J Acquir Immune Defic Syndr. 2004;37(Suppl 2):S78-87.
    • (2004) J Acquir Immune Defic Syndr , vol.37 , Issue.SUPPL 2
    • Fisher, J.D.1    Cornman, D.H.2    Osborn, C.Y.3    Amico, K.R.4    Fisher, W.A.5    Friedland, G.A.6
  • 19
    • 0029550242 scopus 로고
    • What is motivational interviewing?
    • 10.1017/S135246580001643X
    • Rollnick S, Miller WR. What is motivational interviewing? Behav Cogn Psychother. 1995;23(4):325-34.
    • (1995) Behav Cogn Psychother , vol.23 , Issue.4 , pp. 325-334
    • Rollnick, S.1    Miller, W.R.2
  • 20
    • 0035183195 scopus 로고    scopus 로고
    • Motivational interviewing in health care settings: Opportunities and limitations
    • 11137778 10.1016/S0749-3797(00)00254-3 1:STN:280:DC%2BD3M7gvVShtA%3D%3D
    • Emmons KM, Rollnick S. Motivational interviewing in health care settings: opportunities and limitations. Am J Prev Med. 2001;20(1):68-74.
    • (2001) Am J Prev Med , vol.20 , Issue.1 , pp. 68-74
    • Emmons, K.M.1    Rollnick, S.2
  • 27
    • 79955671385 scopus 로고    scopus 로고
    • Strategies to improve adherence and acceptability of hormonal methods of con-traception. status and date
    • 10.1002/14651858.CD004317 21491389
    • Halpern V, Lopez LM, Grimes DA, Gallo MF. Strategies to improve adherence and acceptability of hormonal methods of con-traception. status and date. Cochrane Database Syst Rev. 2011;. doi: 10.1002/14651858.CD004317.
    • (2011) Cochrane Database Syst Rev
    • Halpern, V.1    Lopez, L.M.2    Grimes, D.A.3    Gallo, M.F.4
  • 29
    • 34447624704 scopus 로고    scopus 로고
    • A review of health behaviour theories: How useful are these for developing interventions to promote long-term medication adherence for TB and HIV/AIDS?
    • 17561997 10.1186/1471-2458-7-104
    • Munro S, Lewin S, Swart T, Volmink J. A review of health behaviour theories: how useful are these for developing interventions to promote long-term medication adherence for TB and HIV/AIDS? BMC Public Health. 2007;7(1):104.
    • (2007) BMC Public Health , vol.7 , Issue.1 , pp. 104
    • Munro, S.1    Lewin, S.2    Swart, T.3    Volmink, J.4
  • 30
    • 33745690428 scopus 로고    scopus 로고
    • New York: CHANGE Project (AED) International Center for Research on Women Accessed 17 Sept 2004
    • Kidd R, Clay S. Understanding and challenging HIV stigma: toolkit for action. New York: CHANGE Project (AED) International Center for Research on Women. 2003. Available at http://www.icrw.org/publications/understanding-and- challenging-hiv-stigma-toolkit-action. Accessed 17 Sept 2004.
    • (2003) Understanding and Challenging HIV Stigma: Toolkit for Action
    • Kidd, R.1    Clay, S.2
  • 31
    • 84879016752 scopus 로고    scopus 로고
    • Completed observation of the randomized placebo-controlled phase of iPrEx: Daily oral FTC/TDF pre-exposure HIV prophylaxis among men and trans women who have sex with men
    • Accessed on 25 Sept 2012
    • Grant R, McMahan A, Liu J, et al. Completed observation of the randomized placebo-controlled phase of iPrEx: daily oral FTC/TDF pre-exposure HIV prophylaxis among men and trans women who have sex with men. Sixth IAS Conference on HIV Pathogenesis, Tratement and PRevention, 2011 [abstract WELBC04]. Available at http://pag.ias2011.org/PAGMaterial/IAS2011/PPT/598-642/ grant%20et%20al%20completed%20observation%20final%204.pptx. Accessed on 25 Sept 2012.
    • Sixth IAS Conference on HIV Pathogenesis, Tratement and PRevention, 2011 [Abstract WELBC04]
    • Grant, R.1    McMahan, A.2    Liu, J.3
  • 34
    • 1642471733 scopus 로고    scopus 로고
    • Intervention mapping: Protocol for applying health psychology theory to prevention programmes
    • 14683571 10.1177/1359105304038379
    • Kok G, Schaalma H, Ruiter RA, Van Empelen P, Brug J. Intervention mapping: protocol for applying health psychology theory to prevention programmes. J health Psychol. 2004;9(1):85-98.
    • (2004) J Health Psychol , vol.9 , Issue.1 , pp. 85-98
    • Kok, G.1    Schaalma, H.2    Ruiter, R.A.3    Van Empelen, P.4    Brug, J.5
  • 35
    • 84863725804 scopus 로고    scopus 로고
    • Supporting study product use and accuracy in self-report in the iPrEx study: Next step counseling and neutral assessment
    • 10.1007/s10461-012-0182-5
    • Amico KR, McMahan V, Goicochea P, Vargas L, Marcus JL, Grant RM, et al. Supporting study product use and accuracy in self-report in the iPrEx study: next step counseling and neutral assessment. AIDS Behav. 2012;16(5):1243-59.
    • (2012) AIDS Behav , vol.16 , Issue.5 , pp. 1243-1259
    • Amico, K.R.1    McMahan, V.2    Goicochea, P.3    Vargas, L.4    Marcus, J.L.5    Grant, R.M.6
  • 36
    • 58149154471 scopus 로고    scopus 로고
    • The Information-Motivation-Behavioral Skills model of antiretroviral adherence and its applications
    • 18838059 10.1007/s11904-008-0028-y
    • Fisher JD, Amico KR, Fisher WA, Harman JJ. The Information-Motivation- Behavioral Skills model of antiretroviral adherence and its applications. Curr HIV/AIDS Rep. 2008;5(4):193-203.
    • (2008) Curr HIV/AIDS Rep , vol.5 , Issue.4 , pp. 193-203
    • Fisher, J.D.1    Amico, K.R.2    Fisher, W.A.3    Harman, J.J.4
  • 37
    • 0032494396 scopus 로고    scopus 로고
    • Efficacy of risk-reducing counseling to prevent human immunodefiency virus and sexually transmitted diseases
    • 9777816 10.1001/jama.280.13.1161 1:STN:280:DyaK1cvkvFantA%3D%3D
    • Kamb ML, Fishbein M, Douglas JM Jr, Rhodes F, Rogers J, Bolan G, et al. Efficacy of risk-reducing counseling to prevent human immunodefiency virus and sexually transmitted diseases. JAMA. 1998;280(13):1161-7.
    • (1998) JAMA , vol.280 , Issue.13 , pp. 1161-1167
    • Kamb, M.L.1    Fishbein, M.2    Douglas, Jr.J.M.3    Rhodes, F.4    Rogers, J.5    Bolan, G.6
  • 39
    • 67349130817 scopus 로고    scopus 로고
    • An agenda for advancing the science of implementation of evidence-based HIV prevention interventions
    • 19360464 10.1007/s10461-009-9556-8
    • Norton WE, Amico KR, Cornman DH, Fisher WA, Fisher JD. An agenda for advancing the science of implementation of evidence-based HIV prevention interventions. AIDS Behav. 2009;13(3):424-9.
    • (2009) AIDS Behav , vol.13 , Issue.3 , pp. 424-429
    • Norton, W.E.1    Amico, K.R.2    Cornman, D.H.3    Fisher, W.A.4    Fisher, J.D.5
  • 40
    • 84879028233 scopus 로고    scopus 로고
    • High adherence among HIV-1 serodiscordant couples in the Partners PrEP ancillary adherence study
    • Accessed on 9 Sept 2012
    • Harberer J, Baeten J, Celum C, Katibira E, Ronald, et al. High adherence among HIV-1 serodiscordant couples in the Partners PrEP ancillary adherence study. Miami: International Association for Physicians in AIDS Care. 2012. Available at: http://www.iapac.org/AdherenceConference/presentations/ADH7-80026. pdf. Accessed on 9 Sept 2012.
    • (2012) Miami: International Association for Physicians in AIDS Care
    • Harberer, J.1    Baeten, J.2    Celum, C.3    Katibira, E.4    Ronald5
  • 43
    • 84868153362 scopus 로고    scopus 로고
    • US Food and Drug Administration Accessed on 9 September 2012
    • US Food and Drug Administration. FDA approves first drug for reducing the risk of sexually acquired HIV infection. 2012. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm312210.htm. Accessed on 9 September 2012. International Program of Research on AIDS International Training and Research Programme
    • (2012) FDA Approves First Drug for Reducing the Risk of Sexually Acquired HIV Infection


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.